CLINICAL_TRIALS
trial_result
· 2013-08-21
Clinical Trial Update: Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825) [Phase 2]
Summary
Phase 2 clinical trial evaluating dasatinib (BMS-354825) for chronic lymphocytic leukemia has completed, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2013-08-21